Morning Briefing
Summaries of health policy coverage from major news organizations
Drug Initiative Granted Rights To Develop TB Compounds For Potential Treatment Of NTDs
The Drugs for Neglected Diseases Initiative (DNDi) now has the rights to "develop a class of potential anti-TB compounds" that may also treat Chagas disease, African sleeping sickness and leishmaniasis, Reuters reports.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
